Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Obesity and inflammation].

M Recasens1, W Ricart, J M Fernández-Real

  • 1Unidad de Diabetes, Endocrinología y Nutrición, Hospital Universitari de Girona, Doctor Josep Trueta.

Revista De Medicina De La Universidad De Navarra
|September 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arterial hypertension diagnosis: A problem?

Hipertension y riesgo vascular·2022
Same author

Differences in intraoperative and surgical outcomes between normotensive pheochromocytomas and sympathetic paragangliomas (PPGLs) and hypertensive PPGLs: results from the PHEO-RISK STUDY.

Journal of endocrinological investigation·2022
Same author

[Reply: Importance of the optimal knowledge of healthcare professionals in the initial diagnosis of high blood pressure].

Hipertension y riesgo vascular·2022
Same author

Dysregulation of macrophage PEPD in obesity determines adipose tissue fibro-inflammation and insulin resistance.

Nature metabolism·2022
Same author

A new validated international questionnaire on health professionals' knowledge of hypertension diagnosis.

Hipertension y riesgo vascular·2022
Same author

Obesity status and obesity-associated gut dysbiosis effects on hypothalamic structural covariance.

International journal of obesity (2005)·2021
Same journal

[The interests of the medical class].

Revista de medicina de la Universidad de Navarra·2009
Same journal

[Treatment to conserve fertility in a patient diagnosed with deep pelvic endometriosis].

Revista de medicina de la Universidad de Navarra·2009
Same journal

[Treatment for endometriosis].

Revista de medicina de la Universidad de Navarra·2009
Same journal

[Basic research into endometriosis. Are we going in the right direction?].

Revista de medicina de la Universidad de Navarra·2009
Same journal

[Diagnosis of endometriosis].

Revista de medicina de la Universidad de Navarra·2009
Same journal

Ultrasound study of the myoendometrial border.

Revista de medicina de la Universidad de Navarra·2009
See all related articles

Adipose tissue releases adipokines, impacting metabolic syndrome. Dysregulation of these molecules, like tumor necrosis factor-alpha (TNFalpha) and interleukin-6 (IL-6), contributes to insulin resistance and cardiovascular issues.

Area of Science:

  • Endocrinology
  • Metabolic Syndrome Research
  • Molecular Biology

Background:

  • Adipose tissue secretes various adipokines, including leptin, TNFalpha, interleukins, and adiponectin.
  • Adipokines play a crucial role in regulating metabolic processes and vascular function.
  • Obesity and metabolic syndrome are linked to altered adipokine profiles.

Purpose of the Study:

  • To investigate the role of adipokines in the pathophysiology of metabolic syndrome.
  • To elucidate the mechanisms by which adipokines influence insulin resistance, hypertension, and dyslipidemia.
  • To highlight the contrasting roles of different adipokines in metabolic health.

Main Methods:

  • Analysis of adipokine production by adipocytes.
  • Investigation of the effects of TNFalpha and IL-6 on insulin signaling pathways.

Related Experiment Videos

  • Evaluation of adiponectin levels in relation to metabolic and cardiovascular diseases.

    • Main Results:

    • Increased TNFalpha production by adipose tissue elevates its biological activity, contributing to insulin resistance and associated conditions.
    • Adipocytes are a significant source of IL-6, implicated in hyperlipidemia, diabetes, and hypertension.
    • Adiponectin levels are decreased in obesity and cardiovascular disease, whereas higher levels are protective against atherosclerosis.

    Conclusions:

    • Adipokines are key mediators in the development of metabolic syndrome through diverse metabolic and vascular effects.
    • Targeting specific adipokines may offer therapeutic strategies for metabolic and cardiovascular diseases.
    • Understanding adipokine dysregulation is crucial for managing obesity-related complications.